Gene: GSTZ1
Official Full Name: glutathione S-transferase zeta 1provided by HGNC
Gene Summary: This gene is a member of the glutathione S-transferase (GSTs) super-family which encodes multifunctional enzymes important in the detoxification of electrophilic molecules, including carcinogens, mutagens, and several therapeutic drugs, by conjugation with glutathione. This enzyme catalyzes the conversion of maleylacetoacetate to fumarylacetoacatate, which is one of the steps in the phenylalanine/tyrosine degradation pathway. Deficiency of a similar gene in mouse causes oxidative stress. Several transcript variants of this gene encode multiple protein isoforms. [provided by RefSeq, Jul 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37457 | GSTZ1 Knockout cell line (HeLa) | Human | GSTZ1 | 1:3~1:6 | Negative | Online Inquiry |
KO37458 | GSTZ1 Knockout cell line (HCT 116) | Human | GSTZ1 | 1:2~1:4 | Negative | Online Inquiry |
KO37459 | GSTZ1 Knockout cell line (HEK293) | Human | GSTZ1 | 1:3~1:6 | Negative | Online Inquiry |
KO37460 | GSTZ1 Knockout cell line (A549) | Human | GSTZ1 | 1:3~1:4 | Negative | Online Inquiry |
GSTZ1 Gene Knockout Cell Lines are advanced biological tools developed for the study of the glutathione S-transferase Zeta 1 (GSTZ1) gene, known for its vital roles in drug metabolism and cellular detoxification processes. These cell lines are engineered using CRISPR-Cas9 technology to create specific knockout variants, enabling researchers to investigate the functional consequences of GSTZ1 deficiency in a controlled environment.
The primary function of GSTZ1 is to facilitate the conjugation of glutathione to various substrates, which assists in the detoxification of electrophilic compounds. By employing these knockout cell lines, scientists can elucidate the effects of reduced GSTZ1 activity on cellular responses, metabolic pathways, and susceptibility to toxins. This allows for a deeper understanding of conditions influenced by GSTZ1, including certain cancers and drug sensitivities, making these cell lines invaluable for pharmacological research and toxicology studies.
In research and clinical settings, the GSTZ1 Gene Knockout Cell Lines possess significant advantages over traditional models. They offer high reproducibility and specificity, allowing for clearer and more reliable data interpretation. Furthermore, these cell lines enable the exploration of gene function in complex signaling networks, thereby enhancing the development of targeted therapies.
For researchers and clinicians, the ability to manipulate GSTZ1 pathways provides critical insights that can lead to improved predictive models for drug metabolism and toxicity. Consequently, this knowledge can directly influence therapeutic strategies and personalized medicine approaches.
Our company specializes in providing high-quality bioresearch products and services, ensuring that the GSTZ1 Gene Knockout Cell Lines are rigorously validated and characterized. With our extensive experience in genetic engineering and cell line development, we are committed to empowering scientific innovation and advancements in the biomedical field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.